Submitted manuscripts are subject to a rigorous but speedy peer review process. We aim for a standard review time of less than 2 months. The review process is designed to help authors to improve their manuscripts by giving them constructive comments on how to improve their paper, and to publish only those articles which comply with general quality criteria of a scholarly paper, especially originality, clarity, references to related work and validity of results and conclusions. In addition, we require a translational element to the work or a clear path to clinical application.
When we receive a manuscript, the Managing Editor will first decide whether the manuscript meets the formal criteria specified in the JTEHM template and, in consultation with the Editor in Chief, whether it fits within the scope of the journal. When in doubt, the editor will consult other members of the Editorial Board. Manuscripts are then assigned to an Associate Editor, who sends each paper to 2 external experts for peer review. Authors are required to suggest at least 1 peer-reviewer (who does not have a conflict of interest) during the submission process.
Speed of Peer-Review
Bioengineering is a fast-moving field and we acknowledge the need of our authors to communicate their findings rapidly. We therefore aim to be extremely fast (but still thorough and rigorous) in our peer-review process. However, actual times needed to review and edit papers vary, and primarily depend on the quality of the paper upon first submission. Normally we cannot give any guarantees on the speed of peer-review or publication, but we aim for an average decision time of 2 months after submission for papers sent out for peer-review. There will, however, always be outliers.
Manuscripts should meet the following requirements: the study conducted is ethical; the material is original; the writing is clear; the study methods are appropriate; the data are valid; the conclusions are reasonable and supported by the data; the information is important; there is a clear translational focus or path to clinical application; and the topic is interesting for our readership.
Instructions for Authors
Informed consent, protection of privacy and other human rights are further criteria against which manuscripts involving human subjects will be judged. Papers describing investigations on human or animal subjects must include a statement that the study was approved by the institutional review board.
Our ethical requirements for submitted manuscripts are in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, drawn up by the International Committee of Medical Journal Editors (JAMA 1997;277:927-934). JTEHM also supports and acts in line with the Editorial Policy Statements of the Council of Science Editors.